Patrick F. Smith, PRESIDENT, DRUG Development SOLUTIONS at Certara, Inc. (CERT), sold 5,000 shares at $18.00 ($90K) on 2024-02-20, disclosed to the SEC on 2024-02-21.
Scheduled sale ($90k) by PRESIDENT, DRUG Development SOLUTIONS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CERT | SELL | 2023-06-06 | $823K | — | Filing → |
| CERT | SELL | 2022-11-14 | $32K | — | Filing → |
| CERT | SELL | 2022-08-18 | $177K | — | Filing → |